Stay updated with breaking news from Tim Walbert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Second-Quarter 2022 Results:-- Net Sales of $876.4 Million; Orphan Segment Net Sales Increased 13% to $841.3 Million ---- GAAP Net Income of $61.0 Million; Adjusted EBITDA of $306.6 Million ---- TEPEZZA® (teprotumumab-trbw) Net Sales of $479.8 Million ---- KRYSTEXXA® (pegloticase injection) Net Sales of $167.8 Milli...
--Company Also Makes Fortune Best Workplace for Millennials List for Third Consecutive Year -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named by Seramount (formerly Working
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named to the Fortune Best Workplaces in Chicago 2022 list, ranking No. 3 in the large company category. The list includes 15 top
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the company has won an International Corporate Social Responsibility (CSR) Excellence Award for its partnership with Gift of Adoption to co-create
Horizon Therapeutics plc has confirmed that the company is seeking to recruit 50 people to work in high-end specialist roles in science and engineering in its…